NCT06138054 MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI
| NCT ID | NCT06138054 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Schizophrenia Spectrum Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-04-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to test the feasibility and acceptability of a brief behavioral intervention that combines two treatments, Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT), that have been shown to work in prior research studies. The format of the intervention will be a combination of in-person sessions and remote elements delivered via mobile phone (together called MI-CBTech). The goal of the intervention is to improve community integration in Veterans with serious mental illness (SMI) who have experienced homelessness. A time- and format-matched control arm will include remote mindfulness training. 50 Veterans with SMI experiencing homelessness will be randomized to one of the two arms (25 per arm).
Eligibility Criteria
Inclusion Criteria: * Veterans currently residing at the VA Greater Los Angeles Mental Health Residential Rehabilitation Treatment Program (Domiciliary) * age 18-65 years * diagnosis of non-affective or affective psychotic illness as confirmed by chart review * history of homelessness * sufficiently fluent in English to consent, understand procedures, and complete assessments and intervention * medically and clinically stable (i.e. able to participate in and complete assessments and intervention). Exclusion Criteria: * history of clinically significant neurological disorder determined by medical history (e.g., epilepsy) * history of serious head injury (i.e., loss of consciousness \> 1 hr, neuropsychological sequelae, cognitive rehabilitation post head injury) * evidence of IQ \< 70 or developmental disability * moderate or severe substance use disorder in the past month based on chart review
Contact & Investigator
Amy M Jimenez, PhD
PRINCIPAL INVESTIGATOR
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Frequently Asked Questions
Who can join the NCT06138054 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Schizophrenia Spectrum Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06138054 currently recruiting?
Yes, NCT06138054 is actively recruiting participants. Contact the research team at Amy.Jimenez@va.gov for enrollment information.
Where is the NCT06138054 trial being conducted?
This trial is being conducted at West Los Angeles, United States.
Who is sponsoring the NCT06138054 clinical trial?
NCT06138054 is sponsored by VA Office of Research and Development. The principal investigator is Amy M Jimenez, PhD at VA Greater Los Angeles Healthcare System, West Los Angeles, CA. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.